USD 109.93
(-3.85%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 555.83 Million | 516.76 Million | 471.35 Million | 369.92 Million | 461.91 Million | 516.68 Million |
Net Income | 247.21 Million | 395.66 Million | 269.08 Million | 135.88 Million | 360.54 Million | 249.02 Million |
Depreciation & Amortization | 321.76 Million | 302.4 Million | 279.97 Million | 255.02 Million | 239.75 Million | 244.24 Million |
Deferred income taxes | -13.75 Million | - | -13 Million | -11.92 Million | -12.27 Million | 12.35 Million |
Stock-based compensation | 14.3 Million | 13.7 Million | 13 Million | 11.92 Million | 12.27 Million | 11.71 Million |
Change in working capital | 2.82 Million | -2.84 Million | 13.1 Million | -5.47 Million | -24.16 Million | 15.43 Million |
Other non-cash items | -16.53 Million | -192.16 Million | -90.8 Million | -15.51 Million | -114.21 Million | 16.5 Million |
Investing Cash Flow | -358.32 Million | -785.99 Million | -660.11 Million | -368.38 Million | -316.53 Million | -192.24 Million |
Investments in PPE | -311.12 Million | -416.7 Million | -440.51 Million | -501.93 Million | -409.91 Million | -368.25 Million |
Acquisitions | 1.09 Million | -27.34 Million | -3.11 Million | -3.34 Million | -1.05 Million | 36.96 Million |
Investment purchases | -60.62 Million | -465.11 Million | -369.58 Million | -23.2 Million | -205.92 Million | -14.6 Million |
Sales/Maturities of investments | 28.45 Million | 133.71 Million | 168.99 Million | 183.46 Million | 321.99 Million | 215.77 Million |
Other Investing Activities | -16.12 Million | -10.55 Million | -15.9 Million | -23.35 Million | -21.64 Million | 139.05 Million |
Financing Cash Flow | -33.84 Million | 190.41 Million | -452.96 Million | 661.73 Million | -100.1 Million | -241.3 Million |
Debt repayment | -333.47 Million | -19.44 Million | -277.64 Million | -581.23 Million | -305.04 Million | -57.62 Million |
Dividends payments | -359.19 Million | -347.28 Million | -335.65 Million | -324.59 Million | -313.64 Million | -301.19 Million |
Common Stock Repurchased | -5.01 Million | -4.9 Million | -2.99 Million | -4.05 Million | -4.62 Million | -958 Thousand |
Common Stock Issuance | 131.89 Million | 307.27 Million | 172.98 Million | 99.17 Million | 143.02 Million | 130.91 Million |
Other Financing Activities | 531.94 Million | 254.76 Million | -9.65 Million | 1.47 Billion | 380.18 Million | -12.45 Million |
Accounts receivables | 3.46 Million | -12.07 Million | 1.21 Million | -6.03 Million | -16.12 Million | 917 Thousand |
Accounts payables | 6 Million | 77 Thousand | 6.78 Million | 5.62 Million | 2.32 Million | 2.65 Million |
Inventory | - | - | -6.78 Million | - | -2.32 Million | -2.07 Million |
Other working capital | -6.64 Million | 9.15 Million | 11.88 Million | -5.05 Million | -8.04 Million | 13.93 Million |
Cash at beginning of period | 96.34 Million | 175.16 Million | 816.89 Million | 153.61 Million | 108.33 Million | 25.2 Million |
Cash at end of period | 260 Million | 96.34 Million | 175.16 Million | 816.89 Million | 153.61 Million | 108.33 Million |
Capital Expenditure | -311.12 Million | -416.7 Million | -440.51 Million | -501.93 Million | -409.91 Million | -368.25 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 163.65 Million | -78.81 Million | -641.73 Million | 663.28 Million | 45.28 Million | 83.13 Million |
Free Cash Flow | 244.71 Million | 100.06 Million | 30.83 Million | -132 Million | 52 Million | 148.43 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 63.46 Million | 111.58 Million | 58.01 Million | 67.09 Million | 247.21 Million | 59.39 Million |
Depreciation & Amortization | 87.02 Million | 85.04 Million | 83.4 Million | 82.42 Million | 321.76 Million | 81.73 Million |
Deferred income taxes | - | - | - | -495 Thousand | -13.75 Million | -1.31 Million |
Stock-based compensation | 3.51 Million | 3.47 Million | 4.16 Million | 3.47 Million | 14.3 Million | 3.38 Million |
Change in working capital | -2.74 Million | 25.19 Million | 1.82 Million | -27.78 Million | 2.82 Million | 12.6 Million |
Other non-cash items | -7.17 Million | 107.7 Million | -6.2 Million | -12.09 Million | -16.53 Million | -4.86 Million |
Investing Cash Flow | -122.82 Million | -186.37 Million | -66.94 Million | -69.68 Million | -358.32 Million | -84.43 Million |
Investments in PPE | -58.3 Million | -60.35 Million | -63.74 Million | -75.22 Million | -311.12 Million | -80.31 Million |
Acquisitions | -725 Thousand | - | 725 Thousand | -16.14 Million | 1.09 Million | 165 Thousand |
Investment purchases | 213.87 Million | -213.87 Million | - | 318 Thousand | -60.62 Million | -1.37 Million |
Sales/Maturities of investments | -96.32 Million | 96.32 Million | - | 15.82 Million | 28.45 Million | 1.21 Million |
Other Investing Activities | -122.82 Million | -8.46 Million | -4.64 Million | 5.54 Million | -16.12 Million | -4.12 Million |
Financing Cash Flow | -29.47 Million | 24.95 Million | -229.4 Million | 114.28 Million | -33.84 Million | -66.46 Million |
Debt repayment | -63.37 Million | -68.41 Million | -116.74 Million | -55.94 Million | -333.47 Million | -892 Thousand |
Dividends payments | -92.67 Million | -91.99 Million | -91.88 Million | -90.53 Million | -359.19 Million | -89.61 Million |
Common Stock Repurchased | -286 Thousand | -72 Thousand | -4.61 Million | -40 Thousand | -5.01 Million | -268 Thousand |
Common Stock Issuance | 151.44 Million | 64.62 Million | 6.31 Million | 115.89 Million | 131.89 Million | 9.75 Million |
Other Financing Activities | -24.58 Million | -16.08 Million | -22.47 Million | 144.91 Million | 531.94 Million | 14.55 Million |
Accounts receivables | -5.25 Million | 16.79 Million | -500 Thousand | -7.01 Million | 3.46 Million | 7.46 Million |
Accounts payables | 21.4 Million | -5.81 Million | 7.19 Million | -15.27 Million | 6 Million | 22.71 Million |
Inventory | - | - | - | 15.27 Million | - | -22.71 Million |
Other working capital | 2.5 Million | 14.21 Million | -4.87 Million | -20.76 Million | -6.64 Million | 5.13 Million |
Cash at beginning of period | 113.81 Million | 95.93 Million | 260 Million | 102.79 Million | 96.34 Million | 102.75 Million |
Cash at end of period | 105.6 Million | 103.23 Million | 104.82 Million | 260 Million | 260 Million | 102.79 Million |
Capital Expenditure | -58.3 Million | -60.35 Million | -63.74 Million | -75.22 Million | -311.12 Million | -80.31 Million |
Effect of forex changes on cash | - | - | - | -287.86 Million | - | 141.08 Million |
Net cash flow / Change in cash | -8.21 Million | 7.29 Million | -155.18 Million | 157.21 Million | 163.65 Million | 35 Thousand |
Free Cash Flow | 85.78 Million | 110.05 Million | 77.41 Million | 37.38 Million | 244.71 Million | 70.62 Million |
300414
605098
BIOQ
ZEN
BILL
FRASER